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The database of a major microbiology laboratory in Is-
rael was searched to determine the prevalence of nontuber-
culous mycobacterial lymphadenitis in immunocompetent 
children. We observed a 4-fold increase in nontuberculous 
mycobacteria isolates during 1985–2006, which was attrib-
utable mainly to increased detection of Mycobacterium hae-
mophilum starting in 1996.
N
ontuberculous mycobacteria (NTM) are a common 
cause of nonpyogenic craniofacial lymphadenitis in 
otherwise healthy children. Mycobacterium avium com-
plex (MAC) is the main pathogen (1–3). M. haemophilum 
is traditionally considered a cause of NTM in immunocom-
promised patients (4–7), although a recent study from the 
Netherlands found that it is also common in immunocom-
petent children (8).
The Study
Prompted by the increasing number of M. haemophil-
um isolates identiﬁ  ed at our tertiary medical center in Israel 
in the past decade, we investigated the current prevalence 
and clinical characteristics of NTM lymphadenitis in im-
munocompetent children. The database of our microbiol-
ogy laboratory was searched for all NTM-positive cervi-
cal lymph node cultures of children during 1985–2006. 
In addition, we reviewed records of the Day Hospitaliza-
tion Unit (DHU) for all patients with a diagnosis of NTM 
lymphadenitis from January 1996 (when M. haemophilum 
was  ﬁ   rst isolated in our laboratory) through December 
2006. Data obtained were patient age and sex, Mycobac-
terium species, ethnic background (Jewish/Arab), medical 
history, duration of node enlargement until referral, site 
affected, number of infected sites, size of nodes at initial 
visit (measured by the clinician), discoloration of the skin 
overlying the lymph nodes, and maximal induration in re-
sponse to puriﬁ  ed protein derivative (PPD). Patients with 
M. haemophilum infection were compared with those with 
MAC infection.
All specimens were processed for direct Ziehl-Neelsen 
staining. From 1985 through 1995, specimens were placed 
on solid Lowenstein-Jensen (L-J) medium. Thereafter, liq-
uid MB Redox broth and liquid Bactec 460 12B medium 
(Becton Dickinson Microbiology Systems, Cockeysville, 
MD, USA) were added to the L-J medium. Toward the end 
of 1999, Bactec medium was replaced with the liquid My-
cobacteria Growth Indicator Tube system (Becton Dick-
inson Microbiology Systems). A hemin-containing paper 
strip (X-factor) was regularly placed into the 2 liquid me-
dia, which were incubated with the L-J medium at 37°C 
and 30°C.
Discrete variables were compared between groups by 
using a Pearson χ2 test or Fisher exact test, as appropriate. 
Continuous variables were compared with 1-way analysis 
of variance. A p value <0.05 was considered statistically 
signiﬁ  cant. Data were analyzed by using BMDP software 
(www.statsol.ie/html/bmdp/bmdp_home.html). The study 
was reviewed and approved by the local ethics committee.
The laboratory database contained 111 NTM isolates 
during 1985–2006, of which 77 (69%) were in samples 
from patients who visited the DHU from January 1996 
through December 2006. Species distribution was as fol-
lows: MAC, 54; M. haemophilum, 41; others, 16. The Fig-
ure shows the increase in isolation rate of NTM and M. 
haemophilum since the initial isolation of M. haemophilum 
in March 1996.
The 77 patients managed at our DHU for NTM lymph-
adenitis included 38 boys (49%) and 39 girls 8 months to 
15.5 years of age (median 2.4 years). M. haemophilum was 
isolated from 39 children and MAC from 29. The demo-
graphic and clinical features of these children are shown in 
the Table. The patients in the M. haemophilum group were 
signiﬁ  cantly older than those in the MAC group (mean 4.7 
years vs. 2.3 years; p<0.001); 9 patients with M. haemophi-
lum infection (23%) were >7 years of age compared with 
none with MAC infection. Mean time to referral was sig-
niﬁ  cantly longer in the M. haemophilum group (1.5 months 
vs. 1.1 months; p = 0.045). No statistically signiﬁ  cant dif-
ferences were noted for the other parameters studied.
Conclusions
We speculate that the nearly 4-fold increase in the re-
covery rate of NTM from lymph nodes of immunocom-
petent children in the past 22 years at our center was at-
tributable to the emergence of M. haemophilum as a major 
pathogen of craniocervical lymphadenitis starting in 1996. 
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the other NTM pathogens during the study period. The in-
creased prevalence of NTM cervical lymphadenitis may be 
explained by conversion of our hospital to a tertiary pedi-
atric center in 1991, concomitant with the growing aware-
ness of NTM as a cause of craniocervical lymphadenitis 
among its physicians. Furthermore, the rate of isolation 
of M. haemophilum in this study was 51%. Another study 
from the Netherlands reported a similarly high prevalence 
rate (44%) of M. haemophilum lymphadenitis in immuno-
competent children (8). 
Although the distribution of NTM species may depend 
on local ecologic factors (9), given the wide geographic 
range of M.  haemophilum infection in immunocompro-
mised children (4–7) we would have expected to see re-
ports of increased infection in immunocompetent children 
from >2 countries. We suspect that the change in our labo-
ratory’s processing procedure in 1996 to include broth with 
an iron supplement and incubation of the samples at 30°C 
in addition to 37°C (10) contributed to the high isolation 
rate. Our failure to use these conditions before 1996 could 
have led to an underdiagnosis of M. haemophilum infec-
tion; this may also be true for other laboratories (11). 
These ﬁ  ndings suggest that a failure to isolate a patho-
gen in children with suspected mycocbacterial craniocervi-
cal lymphadenitis, especially those >7 years of age, should 
prompt a targeted laboratory search for M. haemophilum 
by using proper culture conditions or molecular techniques 
(10–12). Identiﬁ  cation of NTM infection has serious clini-
cal implications because it can spare these patients, who 
often have a positive PPD response and cytologic results 
compatible with tuberculosis, unwarranted, prolonged an-
tituberculosis therapy. The mean PPD response in our pa-
tients (>14.5 mm) conﬁ  rms the lack of value of PPD in 
distinguishing NTM infection from tuberculosis (13).
The higher mean age of the children with M. haemo-
philum infection in our series compared with that of chil-
dren in the MAC group is consistent with ﬁ  ndings of a 
study in the Netherlands (8). Our ﬁ  nding may be explained 
by the younger age at which children are exposed to play-
grounds, which are presumably linked to MAC infection, 
than to swimming pools, which are presumably linked to 
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Figure. Distribution of nontuberculous mycobacteria species 
(Mycobacterium avium complex [MAC], M.  haemophilum, 
and others) isolated from craniocervical lymph nodes of 
immunocompetent children in Israel, 1985–2006.
Table. Demographic and clinical characteristics of children with Mycobacterium haemophilum and M. avium complex lymphadenitis* 
Variable M. haemophilum, n = 39  M. avium complex, n = 29  p value 
Mean age, y (range)  4.7 (8 mo–15.5 y)  2.3 (9 mo–7y)  <0.001
Male/female, no. (%)  17/22 (44/56)  16/12 (57/43)  0.33
Ethnic origin, no. (%) 
  Jewish  26 (81.2)  22 (81.5)  1.0
  Arab  6 (18.8)  5 (18.5) 
Mean time to referral, mo (range)  1.47 (0.25–5)  1.1 (0.25–3)  0.045
Site, no. (%) 
  Submandibular  24 (61.5)  13 (46.4)  0.32†
  Neck  7  (17.9)  6  (21.4) 
  Preauricular  3  (7.7)  3  (10.7) 
  Occipital  – 1  (3.6) 
  Cheek  – 4  (14.3) 
  Bilateral submandibular  1 (2.6)  –
  Submandibular and preauricular   3 (7.7)  1 (3.6) 
  Neck and preauricular  1 (2.6)  –
No. infected sites: 1/2, no. (%)  34/5 (87/13)  27/1 (96/4)  0.72
Side: right/left, no. (%)  23/16 (59/41)  21/7 (76/24)  0.20
Mean size of lymphadenopathy, cm
2 (range)  8.7 (1.0–25)  8.9 (1.0–35)  0.93
Skin discoloration: yes/no, no. (%)  15/14 (52/48)  9/9 (50/50)  1.0
PPD: mean maximal induration, cm (range)  17.9 (0–32)  14.5 (0–45)  0.22
*PPD, purified protein derivative. 
†Refers solely to the submandibular site. M. haemophilum and Lymphadenitis, Israel
M. haemophilum infection (8). However, the mean age of 
our patients was lower by >1 year than the age of the Dutch 
children (8), perhaps the result of warmer climate and of the 
younger age of daycare attendees in Israel, both of which 
are associated with longer and earlier exposure to sandpits 
and swimming pools.
In contrast to the results of the Dutch study (8), ethnic-
ity was not a risk factor; the rates of affected Jewish and 
Arab children matched the distribution of these ethnicities 
in the general population of Israel. This ﬁ  nding may reﬂ  ect 
the similar environmental conditions to which these ethnic 
groups are exposed.
Despite the wide variability in the interval from onset 
of lymph node swelling to patient referral for investigation, 
the mean time of ≈5 weeks is consistent with that in previ-
ous studies (1–3). The difference of ≈10 days between the 
2 groups in our study, although statistically signiﬁ  cant, was 
not of clinical importance. The longer interval in the M. 
haemophilum group might have been caused by less atten-
tion parents tend to pay to physical changes in older chil-
dren than in infants. In contrast to the ﬁ  ndings in the Dutch 
study (8), we noted no predilection to multisite infection 
in either group, and all 4 patients with extranodal (cheek) 
involvement were infected with MAC.
In conclusion, M. haemophilum is an emerging patho-
gen in nonpyogenic craniocervical lymphadenitis in immu-
nocompetent children in Israel. M. haemophilum infection 
usually affects older children (>7 years of age) but is other-
wise clinically similar to MAC infection.
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